RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $55,000 | +5.8% | 46,755 | +0.9% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -62.3% | 46,343 | +0.3% | 0.00% | 0.0% |
Q1 2022 | $138,000 | +13.1% | 46,226 | +0.5% | 0.00% | 0.0% |
Q4 2021 | $122,000 | -27.4% | 45,984 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $168,000 | -15.6% | 46,351 | +0.9% | 0.00% | -50.0% |
Q2 2021 | $199,000 | +18.5% | 45,934 | -6.6% | 0.00% | +100.0% |
Q1 2021 | $168,000 | -1.8% | 49,191 | +0.5% | 0.00% | -50.0% |
Q4 2020 | $171,000 | +40.2% | 48,943 | -3.8% | 0.00% | +100.0% |
Q3 2020 | $122,000 | +74.3% | 50,862 | +33.7% | 0.00% | 0.0% |
Q2 2020 | $70,000 | +14.8% | 38,047 | -3.3% | 0.00% | 0.0% |
Q1 2020 | $61,000 | – | 39,349 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |